Since many cancers block the epithelial pathways that encourage tumor growth, TGF-β signaling can have prometastatic effects on the tumor microenvironment even when it does not interfere with the signaling in epithelial cancer cells. This evidence concerns the gene TGFB1 and neoplasm.